Literature DB >> 19172244

The risk allele load accelerates the age-dependent decline in beta cell function.

A Haupt1, H Staiger, S A Schäfer, K Kirchhoff, M Guthoff, F Machicao, B Gallwitz, N Stefan, H-U Häring, A Fritsche.   

Abstract

AIMS/HYPOTHESIS: Among the novel type 2 diabetes risk loci identified by genome-wide association studies, TCF7L2, HHEX, SLC30A8 and CDKAL1 appear to affect beta cell function. In the present study we examined the effect of these genes' risk alleles on the age-dependent decline in insulin secretion.
METHODS: The SNPs rs7903146 (TCF7L2), rs7754840(CDKAL1), rs7923837 (HHEX) and rs13266634 (SLC30A8) were genotyped in 1,412 non-diabetic patients, who were subsequently grouped according to their number of risk alleles. All participants underwent an OGTT. Insulin secretion was assessed by validated indices and proinsulin conversion by calculating AUC(proinsulin)/AUC(insulin).
RESULTS: The number of risk alleles revealed a Gaussian distribution, with most participants carrying four risk alleles. Stratification into groups with low (LAL, up to three alleles), median (MAL, four alleles) and high (HAL, five to eight alleles) allele load resulted in MAL and HAL participants displaying significantly lower insulin secretion and proinsulin conversion than LAL participants (p <or= 0.0014 and p = 0.0185, respectively). In the overall cohort, age was negatively associated with insulin secretion and proinsulin conversion (both p < 0.0001). MAL and HAL participants showed a significantly more pronounced decline in insulin secretion with increasing age than LAL participants (p <or= 0.0325; analysis of covariance), and after stratification for BMI this relationship was maintained in obese, but not non-obese, participants. Proinsulin conversion decreased with increasing age in MAL and HAL, but not LAL, participants (p <or= 0.0003 vs p = 0.2). CONCLUSIONS/
INTERPRETATION: The risk allele load significantly accelerates the age-dependent decline in beta cell function, and this might be of particular importance in obese people.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172244     DOI: 10.1007/s00125-008-1250-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans.

Authors:  Andreas Fritsche; Alexander Madaus; Norbert Stefan; Otto Tschritter; Elke Maerker; Anna Teigeler; Hans Häring; Michael Stumvoll
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

Review 2.  Type-2 diabetes: a cocktail of genetic discovery.

Authors:  H Freeman; R D Cox
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

3.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

4.  Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance.

Authors:  Alena Stancáková; Jussi Pihlajamäki; Johanna Kuusisto; Norbert Stefan; Andreas Fritsche; Hans Häring; Francesco Andreozzi; Elena Succurro; Giorgio Sesti; Trine Welløv Boesgaard; Torben Hansen; Oluf Pedersen; Per Anders Jansson; Ann Hammarstedt; Ulf Smith; Markku Laakso
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

5.  A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study.

Authors:  Harald Staiger; Alena Stancáková; Jone Zilinskaite; Markku Vänttinen; Torben Hansen; Maria Adelaide Marini; Ann Hammarstedt; Per-Anders Jansson; Giorgio Sesti; Ulf Smith; Oluf Pedersen; Markku Laakso; Norbert Stefan; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Diabetes       Date:  2007-11-26       Impact factor: 9.461

6.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

7.  Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

Authors:  Eleftheria Zeggini; Michael N Weedon; Cecilia M Lindgren; Timothy M Frayling; Katherine S Elliott; Hana Lango; Nicholas J Timpson; John R B Perry; Nigel W Rayner; Rachel M Freathy; Jeffrey C Barrett; Beverley Shields; Andrew P Morris; Sian Ellard; Christopher J Groves; Lorna W Harries; Jonathan L Marchini; Katharine R Owen; Beatrice Knight; Lon R Cardon; Mark Walker; Graham A Hitman; Andrew D Morris; Alex S F Doney; Mark I McCarthy; Andrew T Hattersley
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

8.  Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.

Authors:  Harald Staiger; Fausto Machicao; Norbert Stefan; Otto Tschritter; Claus Thamer; Konstantinos Kantartzis; Silke A Schäfer; Kerstin Kirchhoff; Andreas Fritsche; Hans-Ulrich Häring
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

9.  Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.

Authors:  S A Schäfer; O Tschritter; F Machicao; C Thamer; N Stefan; B Gallwitz; J J Holst; J M Dekker; L M 't Hart; L M t'Hart; G Nijpels; T W van Haeften; H U Häring; A Fritsche
Journal:  Diabetologia       Date:  2007-07-28       Impact factor: 10.122

10.  The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies.

Authors:  Stéphane Cauchi; Kevin T Nead; Hélène Choquet; Fritz Horber; Natascha Potoczna; Beverley Balkau; Michel Marre; Guillaume Charpentier; Philippe Froguel; David Meyre
Journal:  BMC Med Genet       Date:  2008-05-22       Impact factor: 2.103

View more
  13 in total

1.  The role of peroxisome proliferator-activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus.

Authors:  D Gupta; T Kono; C Evans-Molina
Journal:  Diabetes Obes Metab       Date:  2010-12       Impact factor: 6.577

2.  PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress.

Authors:  Tatsuyoshi Kono; Geonyoung Ahn; Dan R Moss; Liann Gann; Angel Zarain-Herzberg; Yurika Nishiki; Patrick T Fueger; Takeshi Ogihara; Carmella Evans-Molina
Journal:  Mol Endocrinol       Date:  2012-01-12

3.  Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice.

Authors:  Fan-Yan Wei; Takeo Suzuki; Sayaka Watanabe; Satoshi Kimura; Taku Kaitsuka; Atsushi Fujimura; Hideki Matsui; Mohamed Atta; Hiroyuki Michiue; Marc Fontecave; Kazuya Yamagata; Tsutomu Suzuki; Kazuhito Tomizawa
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

Review 4.  Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.

Authors:  Kasia J Lipska; Harlan Krumholz; Tacara Soones; Sei J Lee
Journal:  JAMA       Date:  2016-03-08       Impact factor: 56.272

Review 5.  Physiologic characterization of type 2 diabetes-related loci.

Authors:  Niels Grarup; Thomas Sparsø; Torben Hansen
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

6.  Genetic risk score constructed using 14 susceptibility alleles for type 2 diabetes is associated with the early onset of diabetes and may predict the future requirement of insulin injections among Japanese individuals.

Authors:  Minoru Iwata; Shiro Maeda; Yutaka Kamura; Atsuko Takano; Hiromi Kato; Shihou Murakami; Kiyohiro Higuchi; Atsushi Takahashi; Hayato Fujita; Kazuo Hara; Takashi Kadowaki; Kazuyuki Tobe
Journal:  Diabetes Care       Date:  2012-06-11       Impact factor: 19.112

7.  Genetic predisposition to type 2 diabetes is associated with impaired insulin secretion but does not modify insulin resistance or secretion in response to an intervention to lower dietary saturated fat.

Authors:  Celia G Walker; Ruth J F Loos; Adrian P Mander; Susan A Jebb; Gary S Frost; Bruce A Griffin; Julie A Lovegrove; Thomas A B Sanders; Les J Bluck
Journal:  Genes Nutr       Date:  2012-02-21       Impact factor: 5.523

8.  Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clamps.

Authors:  Leen M 't Hart; Annemarie M Simonis-Bik; Giel Nijpels; Timon W van Haeften; Silke A Schäfer; Jeanine J Houwing-Duistermaat; Dorret I Boomsma; Marlous J Groenewoud; Erwin Reiling; Els C van Hove; Michaela Diamant; Mark H H Kramer; Robert J Heine; J Antonie Maassen; Kerstin Kirchhoff; Fausto Machicao; Hans-Ulrich Häring; P Eline Slagboom; Gonneke Willemsen; Elisabeth M Eekhoff; Eco J de Geus; Jacqueline M Dekker; Andreas Fritsche
Journal:  Diabetes       Date:  2009-10-06       Impact factor: 9.461

9.  Association of diabetes-related variants in ADCY5 and CDKAL1 with neonatal insulin, C-peptide, and birth weight.

Authors:  Ivette-Guadalupe Aguilera-Venegas; Julia-Del-Socorro Mora-Peña; Marion Velazquez-Villafaña; Martha-Isabel Gonzalez-Dominguez; Gloria Barbosa-Sabanero; Hector-Manuel Gomez-Zapata; Maria-Luisa Lazo-de-la-Vega-Monroy
Journal:  Endocrine       Date:  2021-06-24       Impact factor: 3.633

10.  Use of net reclassification improvement (NRI) method confirms the utility of combined genetic risk score to predict type 2 diabetes.

Authors:  Claudia H T Tam; Janice S K Ho; Ying Wang; Vincent K L Lam; Heung Man Lee; Guozhi Jiang; Eric S H Lau; Alice P S Kong; Xiaodan Fan; Jean L F Woo; Stephen K W Tsui; Maggie C Y Ng; Wing Yee So; Juliana C N Chan; Ronald C W Ma
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.